Our Mission
Our goal is to ensure greater care within emergencies and the intensive care unit. We plan to achieve this by providing products that will revolutionize the medical landscape.
Market Analysis
-
Ceribell: EEG HeadBand
Only provides detection for stroke alongside a slow reponse time.
-
CenSyn: PenEEGTM
Povides stroke and seizure detection but uses cloud based software which is not ideal in an emergency setting.
-
The EncephalopodTM
Provides stroke and seizure detection with software that can be accessed anywhere.
Current Business Model
Our current target market consists of the over 16 thousand ICU doctors in the U.S. and the over 200 thousand EMT professionals in the U.S. The main business model consist of direct hardware sells coupled with a yearly maintenance cost. Futhermore, we'll employ a yearly software subscription.
The Team
Meet the team of highly qualified biomedical engineers